Healthcare (Public Health)

This bill establishes a regulatory framework for the sale of kratom products in Pennsylvania, requiring businesses to register with the Department of Health and prohibiting the sale of synthetic kratom varieties. It mandates that retailers verify customers are at least 21 years old using electronic ID scanners and strictly forbids sharing this data, while also enforcing specific labeling and child-resistant packaging requirements. Additionally, the legislation imposes a tax on natural kratom products and outlines penalties for violations, aiming to standardize oversight and protect public health.

HB 2111 amends Pennsylvania's abortion laws to restrict public facilities and funds. It prohibits publicly owned hospitals, clinics, or government entities from leasing property, entering contracts, or using public funds to support abortion services - except for cases where abortion is necessary to save a mother's life, or to terminate pregnancies resulting from rape or incest that have been reported to law enforcement (with specific documentation requirements). The bill also bans public funds from being used for legal services related to abortion access or restrictions, and requires strict verification of rape/incest reports before funding can be approved for those exceptions. These changes directly affect public health facilities, government agencies, and providers receiving public funding.

SB 946 adds tianeptine - a medication sometimes used for depression but with abuse risks - to Pennsylvania's Schedule II of controlled substances, placing it in a high-risk category due to its potential for abuse and dependence. The bill requires the Pennsylvania Department of Health to monitor tianeptine-related health issues (like overdoses, seizures, or withdrawal symptoms) by collecting data from hospitals, poison control centers, and law enforcement. It also empowers the department to issue public safety advisories and establish reporting rules for healthcare providers. This directly affects tianeptine users, healthcare facilities, and public health officials, focusing on tracking health impacts rather than restricting access immediately. The bill takes effect 60 days after enactment.